Modeling of cancer virotherapy with recombinant measles viruses

From MaRDI portal
Publication:1794429

DOI10.1016/j.jtbi.2008.01.016zbMath1398.92108OpenAlexW2132426756WikidataQ44746330 ScholiaQ44746330MaRDI QIDQ1794429

David Dingli, Stephen J. Russell, Krešimir Josić, Željko Bajzer, Thomas W. Carr

Publication date: 15 October 2018

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2008.01.016




Related Items (47)

Dynamical behavior of a new oncolytic virotherapy model based on gene variationModeling dynamics of cancer radiovirotherapyHopf Bifurcation in Oncolytic Therapeutic Modeling: Viruses as Anti-Tumor Means with Viral Lytic CycleMemory versus effector immune responses in oncolytic virotherapiesSlow-fast model and therapy optimization for oncolytic treatment of tumorsOptimization of virotherapy for cancerEvolution of model specific relative growth rate: its genesis and performance over Fisher's growth ratesDynamics of the tumor-immune-virus interactions: convergence conditions to tumor-only or tumor-free equilibrium pointsMultiscale moving boundary modelling of cancer interactions with a fusogenic oncolytic virus: the impact of syncytia dynamicsTreatment of glioma with virotherapy and TNF-\(\alpha\) inhibitors: analysis as a dynamical systemHopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. IModeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing?Control exponential growth of tumor cells with slow spread of oncolytic virusQuantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeuticsModeling the spatiotemporal dynamics of oncolytic viruses and radiotherapy as a treatment for cancerDynamics of immunotherapy antitumor models with impulsive control strategyA general non-local delay model on oncolytic virus therapyAnalysis of a mathematical model for tumor therapy with a fusogenic oncolytic virusMulti-stability and multi-instability phenomena in a mathematical model of tumor-immune-virus interactionsBifurcations and Chaotic Dynamics in a Tumour-Immune-Virus SystemUltimate tumor dynamics and eradication using oncolytic virotherapyModelling heterogeneity in viral-tumour dynamics: the effects of gene-attenuation on viral characteristicsODE models for oncolytic virus dynamicsThe role of the innate immune system in oncolytic virotherapyModeling treatment of cancer using virotherapy with generalized logistic growth of tumor cellsModelling the spatiotemporal dynamics of chemovirotherapy cancer treatmentBackward Hopf bifurcation in a mathematical model for oncolytic virotherapy with the infection delay and innate immune effectsA mathematical model for cell cycle-specific cancer virotherapyOptimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitorsThe role of viral infectivity in oncolytic virotherapy outcomes: a mathematical studyEnhancement of chemotherapy using oncolytic virotherapy: mathematical and optimal control analysisSpatial model for oncolytic virotherapy with lytic cycle delayMathematical analysis of a mathematical model of chemovirotherapy: effect of drug infusion methodUnnamed ItemNatural killer cells recruitment in oncolytic virotherapy: a mathematical modelBasic stochastic model for tumor virotherapyA mathematical model for oncolytic virus spread using the telegraph equationTreatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injectionsDynamics of tumor virotherapy: A deterministic and stochastic model approachHopf bifurcation analysis of a tumor virotherapy model with two time delaysA two-compartment model interacting with dynamic drugsOncolytic virotherapy for tumours following a Gompertz growth lawMultiscale modelling of cancer response to oncolytic viral therapyA combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-conceptAnalysis of a multiple delays model for treatment of cancer with oncolytic virotherapyA mathematical model of oncolytic virotherapy with time delayBifurcation analysis of the cancer virotherapy system with time delay and diffusion


Uses Software


Cites Work


This page was built for publication: Modeling of cancer virotherapy with recombinant measles viruses